Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
Date:2/27/2013

commercial products address diseases including hereditary angioedema (HAE), seizures, adrenal insufficiency and C. difficile-associated diarrhea (CDAD); for full U.S. prescribing information on our products, please download the package inserts at http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections, and the risk factors included in our periodic filings with the Securities and Exchange Commission for more information on ViroPharma and our business.

Disclosure NoticeCertain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events. Forward looking statements in this press release include our financial guidance for 2013, forecasted future tax rates, our belief that we are in a strong position to generate significant growth for years to come, the rate of future growth, our ability to continue to successfully commercialize our products in the United States and Europe, and our ability to identify and execute upon business development opportunities.

Our actual results may vary depending on a variety of factors, including:

  • our ability to continue to identify Cinryze patients in the United States and Europe at the rate we anticipate and the total number of potential Cinryze patients in the United States and Europe;
  • the size of the market, future growth potential and market share for Cinryze in the United States, E
    '/>"/>

  • SOURCE ViroPharma Incorporated
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    2. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
    3. ViroPharma To Participate In The JMP Securities Healthcare Conference
    4. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
    5. ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
    6. ViroPharma Incorporated Reports Second Quarter 2012 Financial Results
    7. ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference
    8. ViroPharma To Host Analyst And Investor Seminar On September 21, 2012
    9. ViroPharma Incorporated Reports Third Quarter 2012 Financial Results
    10. ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
    11. ViroPharma To Participate In Two Upcoming Healthcare Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... , August 28, 2015 ... Market by Tumor (Breast, Lung, Prostate) Type (Protein & ... (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast ... is expected to reach around 17,689.0 Million USD by ... period of 2015 to 2020. Browse ...
    (Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Originally discovered ... as Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory ... by Senju Pharmaceutical Co., Ltd under the trade ...
    (Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/686gwf/investigation ) ... on China,s Bevacizumab Market ,2010-2019" report to their ... name of Avastin, bevacizumab injection is the first angiogenesis ... approved by CFDA to treat metastatic colorectal cancer. Currently, ... all come from Roche and its subsidiary Genectech. In ...
    Breaking Medicine Technology:Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Bevacizumab Market 2015-2019 2
    ... CAMBRIDGE, England, May 28, 2012 Acacia ... of APD421, in the prevention of post-operative nausea & ... the incidence of nausea and vomiting compared to placebo ... PONV. Vomiting and especially nausea remain a major problem ...
    ... La., May 25, 2012   Albemarle Corporation (NYSE: ... marketer of highly engineered specialty chemicals, announced today that ... ibuprofen by an estimated 15% effective immediately, or as ... ) Albemarle,s ibuprofen and other generic active ...
    Cached Medicine Technology:Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 2Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 3Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 4Albemarle to increase ibuprofen prices 2Albemarle to increase ibuprofen prices 3
    (Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered ... Medicare & Medicaid Services’ (CMS) proposal to mandate bundled payments through the ... “Get Ready for Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new website ... navigation. The most notable change is the responsive web design. Website users will now ... can easily submit quote requests for sod, sign-up for the monthly turf-tips email, and ...
    (Date:8/28/2015)... ... 2015 , ... Where can successful, well educated, or attractive ... up to help quality singles find dating partners or ideal matches. , ... well educated, or attractive. , It updates profiles under the category of " ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... medicine through health promotion and disease prevention, improving a patient’s quality of life ... in the community, including heart disease, cancer, diabetes, HIV/AIDS, STDs, and others. A ...
    (Date:8/27/2015)... ... August 28, 2015 , ... Shortening the school ... performance in mathematics, according to researchers at Georgia State University and Montana State ... July, analyzed the impact of a four-day school week on student achievement by ...
    Breaking Medicine News(10 mins):Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3Health News:Health Clinic Opening and Public Art Unveiling 2Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 2Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 3
    ... obesity expanding to epidemic proportions in the United ... seeking to identify effective means of addressing this ... teachers, researchers and others who met during a ... international conference at the University of Illinois, is ...
    ... New Nutrition Tools to Maximize ... ... Sept. 30 From September 29 to October 12,consumers hungering for ... "Milk Your Budget" sweepstakes at,whymilk.com/value_sweeps. Five visitors each day will have ...
    ... Provider Grows 352%, ATLANTA, Sept. 30 ... process outsourcing, today announced that it,has been named ... privately held,companies in the US. The list is ... of the economy - America,s independent-minded,entrepreneurs., The ...
    ... and NEW YORK, NY, September 30, 2008 ... largest independent, non-profit biomedical research organizations, and the ... global non-profit organization focused solely on AIDS vaccine ... research center dedicated exclusively to solving the most ...
    ... Sept. 29 The Blue Cross and Blue,Shield Association ... for cultivating a workplace culture that supports the,careers of ... the best,places to hold a career in the healthcare ... of the "Best Places to,Launch a Career," while Modern ...
    ... 29 PBM Holdings, Inc., a,global supplier of ... Canada is growing as more retailers are looking ... Canadian parents. Now that,thousands of mothers and fathers ... than private-label formulas and there is a savings,up ...
    Cached Medicine News:Health News:Walking forum report shows need to expand physical activity in schools 2Health News:Walking forum report shows need to expand physical activity in schools 3Health News:Walking forum report shows need to expand physical activity in schools 4Health News:Walking forum report shows need to expand physical activity in schools 5Health News:RevenueMed Named to Inc. 5000 2Health News:Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center 2Health News:Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center 3Health News:Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center 4Health News:Blue Cross and Blue Shield Association Recognized by BusinessWeek, Modern Healthcare and AARP as a Top Workplace 2Health News:Blue Cross and Blue Shield Association Recognized by BusinessWeek, Modern Healthcare and AARP as a Top Workplace 3Health News:Blue Cross and Blue Shield Association Recognized by BusinessWeek, Modern Healthcare and AARP as a Top Workplace 4Health News:Canadian Brand-Name Infant Formulas No Better than Private-Label Formulas 2
    This radiolucent One-piece fixator permits independent mechanical adjustments of the following: Distraction/Compression, Dorsal/Palmar Translation, Radial/Ulnar Translation, Flexion/Extension....
    The Medium External Fixator has a medium Combination Clamp that connects rod to rod or pin to rod as well as a Medium Multi-Pin Clamp that connects pins to rods allowing parallel pin placement....
    ... The Universal Mini External Fixator ... using smooth, thin diameter K ... 2.5 mm). This hold is ... which stabilizes fractures and positions ...
    The Elbow Fixator has ontrolled movement about the axis of rotation of the elbow joint. It is minimally invasive and rapidly applied....
    Medicine Products: